# GlaxoSmithKline LLC, Zebulon, NC – FDA Inspections

Source: https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996

> Inspection records and compliance data for GlaxoSmithKline LLC in Zebulon, North Carolina. 9 FDA inspections on record, last inspected February 20, 2026.

---

## Details

- Name: GlaxoSmithKline LLC
- FEI Number: 1033964
- Address Line 1: 1011 N Arendell Ave
- City: Zebulon
- State: North Carolina
- Zip Code: 27597
- Country Name: United States
- Address: 1011 N Arendell Ave, Zebulon, North Carolina 27597, United States
- Country: United States

## Related Documents

- FDA Inspection 1298596 - GlaxoSmithKline LLC - 2026-02-20 — source: FDA, date: February 20, 2026
- FDA Inspection 1298596 - GlaxoSmithKline LLC - 2026-02-20 — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2026
- [FDA Inspection 1229588 - GlaxoSmithKline LLC - 2024-04-19](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/d81fd5bf-3526-4a54-88e1-61ea98c30e1d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 19, 2024
- FDA Inspection 1043270 - GlaxoSmithKline LLC - 2018-01-26 — classification: No Action Indicated (NAI), source: FDA, date: January 26, 2018
- [FDA Inspection 987392 - GlaxoSmithKline LLC - 2016-04-21](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/cc81defe-1000-49a7-8e5a-3c8096621bd1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2016
- FDA Inspection 940149 - GlaxoSmithKline LLC - 2015-08-21 — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2015
- FDA Inspection 841675 - GlaxoSmithKline LLC - 2013-05-03 — classification: No Action Indicated (NAI), source: FDA, date: May 3, 2013
- FDA Inspection 634702 - GlaxoSmithKline LLC - 2009-11-20 — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2009
- FDA Inspection 609802 - GlaxoSmithKline LLC - 2009-08-24 — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2009
- FDA Inspection 606898 - GlaxoSmithKline LLC - 2009-08-24 — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2009

## Related Companies

- [PharmaMax Pharmaceuticals, Ltd.](https://www.keypedia.com/companies/pharmamax-pharmaceuticals-ltd/36995055-289f-4dec-a34c-fe75a137e22b)
- [Avara Pharmaceutical Technologies, Inc.](https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2)
- [Mylan Technologies, Inc.](https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70)
- [Braintree, A part of SEBELA Pharmaceuticals](https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2)
- [DPT Laboratories Ltd.](https://www.keypedia.com/companies/dpt-laboratories-ltd/3b2d6611-9567-4aa0-8e8c-25e1e0a1714e)
- [HIBROW HEALTHCARE PRIVATE LIMITED](https://www.keypedia.com/companies/hibrow-healthcare-private-limited/c5de7b11-f0fd-48a0-9bf9-e7730c9dc8fe)
- [Ferring International Center S.A.](https://www.keypedia.com/companies/ferring-international-center-sa/d0aeb99b-8d95-4d3d-bbb0-517a29780638)
- [A. R. LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/a-r-life-sciences-private-limited/489d62fd-f360-42e9-a3f9-a49fcdf8dfcb)